InvestorsHub Logo
Followers 219
Posts 247348
Boards Moderated 2
Alias Born 04/06/2006

Re: dDT post# 8584

Sunday, 05/06/2012 9:17:35 PM

Sunday, May 06, 2012 9:17:35 PM

Post# of 53906
(GILD) wsj<>FDA Panel Considers HIV Drug For New Use
Advisers to Weigh Pros, Cons of a $14,000-a-Year Drug for Use in People at High Risk of Getting Virus That Causes AIDS

BY JENNIFER CORBETT DOOREN

A Food and Drug Administration advisory panel this week will decide whether to recommend for the first time that certain healthy but at-risk people take a drug to help prevent them from contracting the virus that causes AIDS.

Approval by the agency would mark another milestone in the three-decade effort to combat HIV and AIDS. Huge advances in drugs to treat infection and its symptoms have allowed patients to live significantly longer and healthier lives for a disease that in the 1980s was a death sentence.

On Thursday, an FDA panel will weigh whether Gilead Sciences Inc., which makes the

http://online.wsj.com/article/SB10001424052702304020104577384502756088234.html?mod=rss_whats_news_us_business

Concentrate, and ASK the 8-Ball!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.